Ilke Sipahi, MD; Steven E. Nissen, MD
Potential Financial Conflicts of Interest: Dr. Sipahi has received an educational grant from Pfizer and lecture honoraria from AstraZeneca. Dr. Nissen has received research support from AstraZeneca, Eli Lilly, Pfizer, Takeda, Sankyo, and Sanofi-Aventis. Dr. Sipahi has also consulted for many pharmaceutical companies without financial compensation. All honoraria, consulting fees, or other payments from any for-profit entity are paid directly to charity so that no income or tax deduction is received.
Sipahi I, Nissen SE. β-Blockers and Progression of Coronary Atherosclerosis. Ann Intern Med. 2008;148:404–405. doi: 10.7326/0003-4819-148-5-200803040-00017
Download citation file:
Published: Ann Intern Med. 2008;148(5):404-405.
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use